CLASS ACTION UPDATE for INO, NCLH and WORX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Levi & Korsinsky, LLP


CLASS ACTION UPDATE for INO, NCLH and WORX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Monday, May 11, 2020 10:40 AM

NEW YORK, NY / ACCESSWIRE / May 11, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

INO Shareholders Click Here: https://www.zlk.com/pslra-1/inovio-pharmaceuticals-inc-loss-form?prid=6438&wire=1
NCLH Shareholders Click Here: https://www.zlk.com/pslra-1/norwegian-cruise-line-holdings-ltd-loss-form?prid=6438&wire=1
WORX Shareholders Click Here: https://www.zlk.com/pslra-1/scworx-corp-loss-submission-form?prid=6438&wire=1

* ADDITIONAL INFORMATION BELOW *

Inovio Pharmaceuticals, Inc. (NASDAQ:INO)

INO Lawsuit on behalf of: investors who purchased February 14, 2020 - March 9, 2020
Lead Plaintiff Deadline : May 12, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/inovio-pharmaceuticals-inc-loss-form?prid=6438&wire=1

According to a filed complaint, throughout the class period, defendants made misleading statements about the company's development of a purported vaccine for the novel coronavirus, artificially inflating the company's share price and resulting in significant investor losses.

Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH)

NCLH Lawsuit on behalf of: investors who purchased February 20, 2020 - March 12, 2020
Lead Plaintiff Deadline : May 11, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/norwegian-cruise-line-holdings-ltd-loss-form?prid=6438&wire=1

According to the filed complaint, during the class period, Norwegian Cruise Line Holdings Ltd. made materially false and/or misleading statements and/or failed to disclose that: (1) the Company was employing sales tactics of providing customers with unproven and/or blatantly false statements about COVID-19 to entice customers to purchase cruises, thus endangering the lives of both their customers and crew members; and (2) as a result, Defendants' statements regarding the Company's business and operations were materially false and misleading and/or lacked a reasonable basis at all relevant times.

SCWorx Corp. (NASDAQ:WORX)

WORX Lawsuit on behalf of: investors who purchased April 13, 2020 - April 17, 2020
Lead Plaintiff Deadline : June 29, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/scworx-corp-loss-submission-form?prid=6438&wire=1

According to the filed complaint, during the class period, SCWorx Corp. made materially false and/or misleading statements and/or failed to disclose that: (1) SCWorx's supplier for COVID-19 tests had previously misrepresented its operations; (2) SCWorx's buyer was a small company that was unlikely to adequately support the purported volume of orders for COVID-19 tests; (3) as a result, the Company's purchase order for COVID-19 tests had been overstated or entirely fabricated; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP


SHARE ARTICLE